A 48-year-old man with obesity (BMI 34), type 2 diabetes, ALT 68 U/L, AST 52 U/L, platelets 240 ×10⁹/L, age 48, and ultrasound showing hepatic steatosis is evaluated. His calculated FIB‑4 score is 0.9. What is the most appropriate management strategy now?